Ex vivo and in vivo experimental investigation of miR-148a-3p as a novel therapy for insulin secretion and type 2 diabetes

Elaine Cowan; Cheng Luan; Jones Ofori; Alexandros Karagiannopoulos; Jonathan LS Esguerra; Charlotte Ling; Enming Zhang; Lena Eliasson

doi:10.1007/s00125-022-05775-w

Ex vivo and in vivo experimental investigation of miR-148a-3p as a novel therapy for insulin secretion and type 2 diabetes

Elaine Cowan, Cheng Luan, Jones Ofori, Alexandros Karagiannopoulos, Jonathan LS Esguerra, Charlotte Ling, Enming Zhang, Lena Eliasson

Research output: Contribution to journal › Published meeting abstract › peer-review

Original language	English
Article number	457
Journal	Diabetologia
Volume	65
Issue number	Suppl 1
DOIs	https://doi.org/10.1007/s00125-022-05775-w
Publication status	Published - 2022
Event	EASD, European Association for the Study of Diabetes, 58th annual meeting, - Stockholm online Duration: 2022 Sept 19 → 2022 Sept 23

Subject classification (UKÄ)

Endocrinology and Diabetes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00125-022-05775-w

Cite this

@article{403b106db92e4d39816691aa10d648be,

title = "Ex vivo and in vivo experimental investigation of miR-148a-3p as a novel therapy for insulin secretion and type 2 diabetes",

author = "Elaine Cowan and Cheng Luan and Jones Ofori and Alexandros Karagiannopoulos and Esguerra, {Jonathan LS} and Charlotte Ling and Enming Zhang and Lena Eliasson",

year = "2022",

doi = "10.1007/s00125-022-05775-w",

language = "English",

volume = "65",

journal = "Diabetologia",

issn = "1432-0428",

publisher = "Springer",

number = "Suppl 1",

note = "EASD, European Association for the Study of Diabetes, 58th annual meeting, ; Conference date: 19-09-2022 Through 23-09-2022",

}

TY - JOUR

T1 - Ex vivo and in vivo experimental investigation of miR-148a-3p as a novel therapy for insulin secretion and type 2 diabetes

AU - Cowan, Elaine

AU - Luan, Cheng

AU - Ofori, Jones

AU - Karagiannopoulos, Alexandros

AU - Esguerra, Jonathan LS

AU - Ling, Charlotte

AU - Zhang, Enming

AU - Eliasson, Lena

PY - 2022

Y1 - 2022

U2 - 10.1007/s00125-022-05775-w

DO - 10.1007/s00125-022-05775-w

M3 - Published meeting abstract

SN - 1432-0428

VL - 65

JO - Diabetologia

JF - Diabetologia

IS - Suppl 1

M1 - 457

T2 - EASD, European Association for the Study of Diabetes, 58th annual meeting,

Y2 - 19 September 2022 through 23 September 2022

ER -

Ex vivo and in vivo experimental investigation of miR-148a-3p as a novel therapy for insulin secretion and type 2 diabetes

Subject classification (UKÄ)

UN SDGs

Access to Document

Fingerprint

Cite this